Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C12H18N4O4PS.Cl.2H2O |
| Molecular Weight | 416.818 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.[Cl-].CC1=C(CCOP(O)(O)=O)SC=[N+]1CC2=CN=C(C)N=C2N
InChI
InChIKey=FANVXQCOBPOPEG-UHFFFAOYSA-N
InChI=1S/C12H17N4O4PS.ClH.2H2O/c1-8-11(3-4-20-21(17,18)19)22-7-16(8)6-10-5-14-9(2)15-12(10)13;;;/h5,7H,3-4,6H2,1-2H3,(H3-,13,14,15,17,18,19);1H;2*1H2
Monophosphothiamine is thiamine derivative used for the treatment of neuritis, polyneuritis, asthenic conditions (weakness), as an additional remedy for chronic blood circulation insufficiency, chronic gastritis accompanied by motor and secretory disorders functions of the stomach. Monophosphothiamine underwent metabolic phosphorylation to active metabolite thiamine pyrophosphate, that acts as a coenzyme in the different metabolic process.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
273724-21-3
Created by
admin on Sat Dec 16 18:11:25 GMT 2023 , Edited by admin on Sat Dec 16 18:11:25 GMT 2023
|
PRIMARY | |||
|
J75F6GA5EP
Created by
admin on Sat Dec 16 18:11:25 GMT 2023 , Edited by admin on Sat Dec 16 18:11:25 GMT 2023
|
PRIMARY | |||
|
DTXSID501036039
Created by
admin on Sat Dec 16 18:11:25 GMT 2023 , Edited by admin on Sat Dec 16 18:11:25 GMT 2023
|
PRIMARY | |||
|
100000176632
Created by
admin on Sat Dec 16 18:11:25 GMT 2023 , Edited by admin on Sat Dec 16 18:11:25 GMT 2023
|
PRIMARY | |||
|
91886578
Created by
admin on Sat Dec 16 18:11:25 GMT 2023 , Edited by admin on Sat Dec 16 18:11:25 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD
